右美托咪定对全麻患儿血糖和血钾的影响:随机对照试验安全性终点的二次分析
结果显示麻醉诱导后血糖轻度升高、血钾降低,15分钟时血糖升高与右美托咪定剂量呈线性关系,30分钟时无明显剂量效应。
要点
- 右美托咪定0.25-0.75 µg/kg用于患儿全麻诱导后,15分钟血糖升高呈剂量依赖性。
- 血钾在给药后15和30分钟较基线降低,但未见右美托咪定的明显影响。
- 血糖和血钾变化幅度小,属初步安全性数据,需进一步研究。
核心结论
- 儿童麻醉诱导后可见血糖轻度升高和血钾降低,15分钟血糖升高程度取决于右美托咪定剂量。
主要发现
- 15分钟血糖较基线估计变化为0.37 mmol/L(95%CI 0.29-0.45 mmol/L),30分钟为0.05 mmol/L(95%CI 0.00-0.10 mmol/L)。
- 15分钟血糖呈线性剂量反应关系(1.07 mmol/L/μg/kg,95%CI 0.57-1.58 mmol/L/μg/kg),30分钟无明显效应(0.15 mmol/L/μg/kg,95%CI -0.40至0.70 mmol/L/μg/kg)。
- 血钾较基线降低,15分钟平均差值为-0.20 mEq/L(95%CI -0.28至-0.12 mEq/L),30分钟为-0.12 mEq/L(95%CI -0.15至-0.08 mEq/L),但两个时间点均未见右美托咪定的明显影响。
临床怎么用
- 患儿使用右美托咪定期间应关注血糖和血钾变化,尤其15分钟时血糖升高呈剂量依赖性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dexmedetomidine is a highly selective α2-adrenergic agonist, which is increasingly used in pediatric anesthesia and intensive care. Potential adverse effects that have not been rigorously evaluated in children include its effects on blood glucose and serum potassium concentrations, which are relevant due to the associations of derangements of both parameters with undesired outcomes. We investigated the effects of 3 different doses of dexmedetomidine on these outcomes in a randomized controlled trial in children undergoing elective surgery. METHODS: Sixty-four American Society of Anesthesiologists I-II children were randomized to receive either dexmedetomidine 0.25 µg/kg, dexmedetomidine 0.5 µg/kg, dexmedetomidine 0.75 µg/kg, or 0 µg/kg (control), as a bolus administered over 60 seconds after induction of anesthesia. Changes in plasma glucose and serum potassium concentrations were measured in venous blood sampled before and at 15 and 30 minutes after study drug administration. Data were plotted within and between groups and analyzed using a constrained longitudinal data approach. RESULTS: Forty-nine children completed the study. Mean glucose levels at 15 and 30 minutes were elevated with estimated changes from baseline of 0.37 mmol/L (95% CI, 0.29-0.45 mmol/L) and 0.05 mmol/L (95% CI, 0.00-0.10 mmol/L), respectively. At 15 minutes, there was a linear dose-response relationship (1.07 mmol/L/μg/kg [95% CI, 0.57-1.58 mmol/L/μg/kg]), but there was no appreciable effect of dexmedetomidine at 30 minutes (0.15 mmol/L/μg/kg [95% CI, -0.40 to 0.70 mmol/L/μg/kg]). Potassium levels were depressed relative to baseline, with a mean difference at 15 minutes of -0.20 mEq/L (95% CI, -0.28 to -0.12 mEq/L) and at 30 minutes of -0.12 mEq/L (95% CI, -0.15 to -0.08 mEq/L), but there was no appreciable effect of dexmedetomidine at either time. CONCLUSIONS: Small elevations in glucose and decreases in potassium were observed after induction of anesthesia in children. The elevation in glucose at 15 minutes depended on the dose of dexmedetomidine administered. These preliminary data warrant further investigation.
引用
- Görges M, Poznikoff AK, West NC, et al. Effects of Dexmedetomidine on Blood Glucose and Serum Potassium Levels in Children Undergoing General Anesthesia: A Secondary Analysis of Safety Endpoints During a Randomized Controlled Trial. Anesth Analg. 2019. PMID: 31008751. doi:10.1213/ANE.0000000000004154
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。